Neuland Laboratories Reports Over Sixfold Profit Increase and Revenue Doubling in Q4FY26
1 hour agoBusiness
31LENS
2 Sources
TBNthebalanced.news

Neuland Laboratories Reports Over Sixfold Profit Increase and Revenue Doubling in Q4FY26

Neuland Laboratories reported a strong Q4FY26 performance with consolidated net sales rising 136% year-on-year to Rs 776.3 crore and net profit increasing over sixfold to Rs 213 crore. EBITDA also grew significantly to Rs 319 crore, reflecting improved operational efficiency. For FY26, total income reached Rs 2,053.1 crore with EBITDA at Rs 603.4 crore. CEO Saharsh Davuluri highlighted ongoing strategic investments in peptide manufacturing and R&D to support future growth and emphasized focus on execution and customer satisfaction.

Political Bias
0%100%0%
Sentiment
78%
AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 13 May 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 2 sources
● Left 0%● Center 100%● Right 0%

The articles primarily present corporate financial results and management commentary without political framing. The coverage focuses on business performance and strategic plans, reflecting a neutral, market-oriented perspective. There is no evident political bias, as the sources emphasize factual reporting and company statements rather than political implications or partisan viewpoints.

Sentiment — Positive (78/100)

The overall sentiment is positive, highlighting significant financial growth and operational improvements. The tone is optimistic, supported by CEO remarks on strategic investments and future prospects. While the coverage is upbeat, it remains factual and avoids exaggeration, maintaining a professional and balanced tone throughout.

How 2 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
economictimesNeuland Laboratories shares rally 7 as profit jumps seven-fold and revenue doubles in Q4CenterPositive
moneycontrolNeuland Lab Consolidated March 2026 Net Sales at Rs 776.25 crore, up 136.4 Y-o-Y- Moneycontrol.comCenterPositive

Coverage timeline

moneycontrol broke this story on 12 May, 01:24 pm. Other outlets followed.

  1. 1
    moneycontrol12 May, 01:24 pm
    Neuland Lab Consolidated March 2026 Net Sales at Rs 776.25 crore, up 136.4 Y-o-Y- Moneycontrol.com
  2. 2
    economictimes13 May, 05:22 am
    Neuland Laboratories shares rally 7 as profit jumps seven-fold and revenue doubles in Q4

Lens Score breakdown

31/100
Public interest0/100
Coverage gap100%

Well-covered story — coverage matches public importance.

Who's involved

Institutions and figures named across source coverage.

Corporate
Neuland LaboratoriesChief Executive Officer and Managing Director

Story context

Category
Business
Sources analysed
2
Last analysed
13 May 2026
Key entities
CroreIndian rupeeNeulandNet incomeNational Stock Exchange of IndiaEarnings before interest, taxes, depreciation, and amortizationPharmaceutical industryChief executive officerCustomer satisfactionFiscal yearMoleculeItalian Social Republic